In AML patients FLT3/ITD and/or genomic breakpoints of different fusion genes (PML/RARalpha, CBFbeta/MYH11, AML1/ETO, MLL/AF6, MLL/AF9, and MLL/AF10) were used as clonal markers. This evidence concerns the gene RUNX1T1 and acute myeloid leukemia.